Hormel Foods through its incubator arm 199 Ventures has partnered with The Better Meat Co. to develop a process of making mycoprotein out of a potato-based fermentation.
The partnership would be tapping Better Meat’s technology in developing the process of creating the mycoprotein trade-named Rhiza.
Better Meat's process involves feeding potatoes to fungi, which in turn convert them into a “pale-colored, neutral-tasting ingredient” similar to chicken meat.
Founded in 1891, Minnesota-based Hormel has primarily been a meat company throughout much of its history, responsible for such meat products as Spam and Hormel Corned Beef.
But in recent years, Hormel has been shifting away from its “meat-centric reputation.”
Hormel CEO Jim Snee said in February that he soon expects at least 25 percent of their sales to come from non-meat products.
According to Fred Halvin, vice president of corporate development at Hormel Foods, with food culture changing rapidly, they would want to address the people's curiosity and willingness to try great tasting, plant-based proteins.
Halvin added that as a global branded food company, Hormel would want to offer delicious and convenient mycoprotein and plant-based protein products.
A Hormel spokesman said the company acknowledges that the alternative protein market has “a high growth trajectory.” He added Hormel Foods want to make sure that it to grow their product offerings in those categories.


Asian Stocks Rise as Oil Falls, Fed and Big Tech Earnings Take Center Stage
Neuralink Expands Brain Implant Trials with 12 Global Patients
Shein Reports $99 Million Loss Ahead of Hong Kong IPO as U.S. Tariffs Hit Sales
CATL Shares Jump as $5.6 Billion Buyback Signals Confidence in Long-Term Growth
Nvidia Eyes $250B Guarantee for OpenAI’s Massive Ohio AI Data Center Project
Gold Price Holds Above $4,000 as Fed Rate Hike Bets Rise on Oil-Driven Inflation
NASA's Artemis II Crew Arrives in Florida for Historic Moon Mission
Intel Stock Slips After Earnings Rally Despite Strong AI-Driven Revenue Growth
US Stock Futures Rally as Oil Prices Drop Ahead of Fed Meeting and Big Tech Earnings
Rubio Rejects AI ‘Kill Switch’ Claims as U.S. Defends American Technology Abroad
Tabletop particle accelerator could transform medicine and materials science
BOJ Expected to Hold Rates Steady While Signaling More Hikes Ahead
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook
Zabka Shares Drop 10% as Seven & i Abandons Investment Plans 



